Return On Equity of Corbus Pharmaceuticals Holdings, Inc. from 30 Jun 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 31 Dec 2025.
  • Corbus Pharmaceuticals Holdings, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -66%, a 111% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Equity for 2025 was -66%, a 111% decline from 2024.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Equity for 2024 was -31%, a 97% increase from 2023.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Equity for 2023 was -920%, a 908% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Corbus Pharmaceuticals Holdings, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -66% -35% -111% 01 Oct 2025 31 Dec 2025
Q3 2025 -57% -15% -35% 01 Jul 2025 30 Sep 2025
Q2 2025 -44% +21% +33% 01 Apr 2025 30 Jun 2025
Q1 2025 -37% +98% +73% 01 Jan 2025 31 Mar 2025
Q4 2024 -31% +889% +97% 01 Oct 2024 31 Dec 2024
Q3 2024 -42% +278% +87% 01 Jul 2024 30 Sep 2024
Q2 2024 -65% +118% +65% 01 Apr 2024 30 Jun 2024
Q1 2024 -135% +8.7% +6% 01 Jan 2024 31 Mar 2024
Q4 2023 -920% -829% -908% 01 Oct 2023 31 Dec 2023
Q3 2023 -320% -245% -325% 01 Jul 2023 30 Sep 2023
Q2 2023 -183% -128% -235% 01 Apr 2023 30 Jun 2023
Q1 2023 -144% -89% -163% 01 Jan 2023 31 Mar 2023
Q4 2022 -91% -33% -58% 01 Oct 2022 31 Dec 2022
Q3 2022 -75% -15% -25% 01 Jul 2022 30 Sep 2022
Q2 2022 -55% +72% +57% 01 Apr 2022 30 Jun 2022
Q1 2022 -55% +127% +70% 01 Jan 2022 31 Mar 2022
Q4 2021 -58% +248% +81% 01 Oct 2021 31 Dec 2021
Q3 2021 -60% +425% +88% 01 Jul 2021 30 Sep 2021
Q2 2021 -126% +305% +71% 01 Apr 2021 30 Jun 2021
Q1 2021 -182% +101% +36% 01 Jan 2021 31 Mar 2021
Q4 2020 -306% -78% -34% 01 Oct 2020 31 Dec 2020
Q3 2020 -485% -316% -187% 01 Jul 2020 30 Sep 2020
Q2 2020 -431% -291% -208% 01 Apr 2020 30 Jun 2020
Q1 2020 -283% -116% -69% 01 Jan 2020 31 Mar 2020
Q4 2019 -228% -111% -96% 01 Oct 2019 31 Dec 2019
Q3 2019 -169% -81% -91% 01 Jul 2019 30 Sep 2019
Q2 2019 -140% -61% -78% 01 Apr 2019 30 Jun 2019
Q1 2019 -167% -91% -120% 01 Jan 2019 31 Mar 2019
Q4 2018 -116% -40% -53% 01 Oct 2018 31 Dec 2018
Q3 2018 -89% +7.5% +7.8% 01 Jul 2018 30 Sep 2018
Q2 2018 -79% +28% +27% 01 Apr 2018 30 Jun 2018
Q1 2018 -76% +42% +35% 01 Jan 2018 31 Mar 2018
Q4 2017 -76% +97% +56% 01 Oct 2017 31 Dec 2017
Q3 2017 -96% +33% +25% 01 Jul 2017 30 Sep 2017
Q2 2017 -107% -0.01% -0.01% 01 Apr 2017 30 Jun 2017
Q1 2017 -118% +4.7% +3.9% 01 Jan 2017 31 Mar 2017
Q4 2016 -173% -61% -54% 01 Oct 2016 31 Dec 2016
Q3 2016 -129% -22% -21% 01 Jul 2016 30 Sep 2016
Q2 2016 -107% -8.2% -8.2% 01 Apr 2016 30 Jun 2016
Q1 2016 -122% 01 Jan 2016 31 Mar 2016
Q4 2015 -112% 01 Oct 2015 31 Dec 2015
Q3 2015 -107% 01 Jul 2015 30 Sep 2015
Q2 2015 -99% 01 Apr 2015 30 Jun 2015

Corbus Pharmaceuticals Holdings, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -66% -35% -111% 01 Jan 2025 31 Dec 2025
2024 -31% +889% +97% 01 Jan 2024 31 Dec 2024
2023 -920% -829% -908% 01 Jan 2023 31 Dec 2023
2022 -91% -33% -58% 01 Jan 2022 31 Dec 2022
2021 -58% +248% +81% 01 Jan 2021 31 Dec 2021
2020 -306% -78% -34% 01 Jan 2020 31 Dec 2020
2019 -228% -111% -96% 01 Jan 2019 31 Dec 2019
2018 -116% -40% -53% 01 Jan 2018 31 Dec 2018
2017 -76% +97% +56% 01 Jan 2017 31 Dec 2017
2016 -173% -61% -54% 01 Jan 2016 31 Dec 2016
2015 -112% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.